Tatva Chintan Pharma Chem vs Nifty 50: Returns Compared
- October 12, 2026
- Posted by: Kunal Singla
- Category: Market
Tatva Chintan Pharma Chem share price Rs 1,804.80 on NSE. Tatva Chintan Pharma Chem vs Nifty 50 over 1 year: +68.80% vs -10.93%. 52-week high Rs 2,008.70, low Rs 1,044.10.
Quick Answer
Tatva Chintan Pharma Chem vs Nifty 50 favours the stock: Tatva Chintan Pharma Chem has beaten the index across all five time frames measured, including a 1-year return of +68.80% against -10.93% for the Nifty 50. Over three years, Tatva Chintan Pharma Chem gained 16.47% while the Nifty 50 gained 13.77%, a gap of 2.70 percentage points in its favour. At Rs 1,804.80, Tatva Chintan Pharma Chem is 10.2% below its 52-week high of Rs 2,008.70 and 72.9% above its 52-week low of Rs 1,044.10. Returns use NSE closing prices to 9 October 2026, and past performance does not indicate future results.
Tatva Chintan Pharma Chem vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Tatva Chintan Pharma Chem trades on the NSE under the symbol TATVA, and its 1-month return of +12.19% compares with -3.75% for the Nifty 50 over the same period.
The Tatva Chintan Pharma Chem vs Nifty 50 comparison matters because Tatva Chintan Pharma Chem is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Tatva Chintan Pharma Chem share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 9 October 2026.
Also read – Sula Vineyards vs Nifty 50: Returns Compared
Click Here – Get Free Investment Predictions
Tatva Chintan Pharma Chem vs Nifty 50: Performance at a Glance
The table below sets out the Tatva Chintan Pharma Chem vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 9 October 2026.
| Time Frame | Tatva Chintan Pharma Chem Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | +12.19% | -3.75% | +15.94 pp |
| 3 Months | +36.06% | -6.97% | +43.03 pp |
| 6 Months | +50.12% | -6.36% | +56.48 pp |
| 1 Year | +68.80% | -10.93% | +79.73 pp |
| 3 Years | +16.47% | +13.77% | +2.70 pp |
On the Tatva Chintan Pharma Chem vs Nifty 50 scorecard, Tatva Chintan Pharma Chem has beaten the index over the latest 1-year window, returning +68.80% against -10.93% for the Nifty 50, a difference of 79.73 percentage points. That is also the widest gap anywhere in the table. The direction differs over the past year: Tatva Chintan Pharma Chem moved up while the Nifty 50 moved down.
Check the Univest Screener for live Tatva Chintan Pharma Chem and Nifty 50 data
Latest Close and 52-Week Range: Tatva Chintan Pharma Chem and the Nifty 50
| Instrument | Latest Close | 52-Week High | 52-Week Low | Vs 52-Week High |
|---|---|---|---|---|
| Tatva Chintan Pharma Chem | Rs 1,804.80 | Rs 2,008.70 | Rs 1,044.10 | -10.2% |
| Nifty 50 | 22,520.45 | 26,373.20 | 22,179.90 | -14.6% |
Tatva Chintan Pharma Chem closed at Rs 1,804.80 on 9 October 2026, which is 10.2% below its 52-week high of Rs 2,008.70 and 72.9% above its 52-week low of Rs 1,044.10. The Nifty 50 closed at 22,520.45, 14.6% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.
Why the Tatva Chintan Pharma Chem vs Nifty 50 Gap Exists
Tatva Chintan Pharma Chem can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Tatva Chintan Pharma Chem has traded between Rs 1,044.10 and Rs 2,008.70, a spread of 92.4% from low to high, against 18.9% for the Nifty 50.
Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move Tatva Chintan Pharma Chem’s price sharply in either direction, while the Nifty 50’s return reflects the blended earnings of its constituents and is far less exposed to any single company’s news.
Download the Univest iOS App or Univest Android App to track Tatva Chintan Pharma Chem and Nifty 50 live on the go.
Tatva Chintan Pharma Chem vs Nifty 50: Has Tatva Chintan Pharma Chem Beaten the Benchmark?
Yes, over the past year. Tatva Chintan Pharma Chem returned +68.80% against -10.93% for the Nifty 50, a lead of 79.73 percentage points. Across all five time frames measured, Tatva Chintan Pharma Chem is ahead of the index.
Risks of the Tatva Chintan Pharma Chem vs Nifty 50 Comparison
Point-to-point returns can mislead, and the Tatva Chintan Pharma Chem vs Nifty 50 comparison is no exception. A different start date would shift every figure in the table above, and past performance does not indicate how either Tatva Chintan Pharma Chem or the Nifty 50 will perform from here.
Also read – TD Power Systems vs Nifty 50: Share Price Performance Compared
Tatva Chintan Pharma Chem carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 1,044.10 to Rs 2,008.70 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.
Conclusion
Tatva Chintan Pharma Chem vs Nifty 50 currently reads in the stock’s favour on every time frame measured, led by the one year window. Even so, a single stock’s record can reverse quickly, so investors should weigh Tatva Chintan Pharma Chem’s volatility, liquidity and sector concentration alongside its returns and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Tatva Chintan Pharma Chem outperformed the Nifty 50 in the last year?
Ans. Yes. Tatva Chintan Pharma Chem returned +68.80% over the past year while the Nifty 50 returned -10.93%, based on NSE closing prices to 9 October 2026.
How does Tatva Chintan Pharma Chem vs Nifty 50 look over 3 years?
Ans. Over three years Tatva Chintan Pharma Chem has returned +16.47% compared with the Nifty 50’s +13.77%, so in the Tatva Chintan Pharma Chem vs Nifty 50 comparison the stock has been ahead over this horizon.
What is the Tatva Chintan Pharma Chem share price today compared to Nifty 50?
Ans. Tatva Chintan Pharma Chem share price closed at Rs 1,804.80 on NSE on 9 October 2026, while the Nifty 50 closed at 22,520.45 in the same session.
What is the 52-week high and low of Tatva Chintan Pharma Chem?
Ans. Tatva Chintan Pharma Chem’s 52-week high is Rs 2,008.70 and its 52-week low is Rs 1,044.10, based on NSE data. The latest close of Rs 1,804.80 is 10.2% below the high.
Why does Tatva Chintan Pharma Chem show bigger price swings than the Nifty 50?
Ans. Tatva Chintan Pharma Chem carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Tatva Chintan Pharma Chem has traded in a 92.4% low-to-high range against 18.9% for the index, a key reason the Tatva Chintan Pharma Chem vs Nifty 50 return gap varies across time frames.
Is Tatva Chintan Pharma Chem a good long-term investment compared to a Nifty 50 index fund?
Ans. Tatva Chintan Pharma Chem’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Tatva Chintan Pharma Chem vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
